Member Info for skid35

This is a real expression of faith in the company.
But at this price of is backed by a significant backing of cash within arix, so downside is limited

Wool,
1. You invested in an early stage growth company where there may not be immediate profits as the company ramps revenue, why is this a surprise?
2. You have access to the remuneration report in the annual report to understand policy on salary / bonus / options. Are you suggesting they should have an employment contract which does not have a base salary. Why is it a surprise?
3. It is standard for employees to be able to recover legitimate expenses incurred on company business in line with the company expense policy, why is this a surprise?

The surprise to me is that the share price is not responding the positive outlook and hopefully breakeven / profit expectation for 2020, this is not the direct responsibility of the bod.
I for one are happy for lower profit next year for additional headcount costs providing revenue opportunities 2-5 years out, especially in the pharma area.

Stick this in the bottom draw for two years and do not touch it, then revisit it.

As all the contributors to the board will say, just stick in for at least two years here.

Uhlf - how many shares are you now?

Will the deal through will be really interesting to see the year end results. I particular level of cash, holdings valuation and movement and discount to nav (and discount to nav taking cash out).
I think my best stock this year.

"Investment money" is always dead until the price moves.
It is interesting that opti now has a very restricted range in the last two months between 50 and 56p, everyone waiting for confirmation of results early 2021. I have been adding to my holding when it gets near 50p and now have c £55/60k in opti, looking forward to results but also the next 2-3 years.

Hard to understand the impact to a general shareholder who is not part of the book build, as a rule I do not like selective shareholder rights which favours directors and their city mates.
The most British of general meeting s being held in a small village hall, will they do a raffle as well?

Will read a few more times, but any legal / company secretarial types on the board to provide a nice summary would be welcome.

No spare funds but too cheap so sold out of a 3 year holding in Pacific horizon, bought in below 30p this morning.
Nice three hour bike ride in the chilterns and coffee at velolife, now back to see the price rise.
As most contributors here a long term investor, when this does go up there will not be too many sellers from this board.

I'm still zero on aj bell.
Anyone written to investor relations or got an email address ?

Last one honest 61.5k at an average 20.5p which can easily be both attained and passed with half decent results.
I have not intended to be be overly negative here, just to highlight that the share price at its current level may not be a One way street the new investors believe. I hope they have got themselves a bargain.

Surprised.

I think everyone must be getting p##### off with my posts here (no need to confirm!). Last post from me until results, which I sincerely hope support a price rise to 25-30p and have the company back on track for growth in the 2-4 year period.

I don't believe we are at odds in the short term opportunity for a decent price rise, but it's not a guarantee.

On specific issues.
1. Investors chronicle and Simon Thompson are not always right, but it has the unbelievable ability to move the market in small shares. From their recommendation in the past on kromek in the past they clearly do not have an inside track.
2. From your second paragraph we agreed the balance sheet should not be used as a valuation of a tech company, using nav to value kromek or support the share price shows how poorly the company has performed.
3. I do invest in individual shares overseas but own both tesla and Apple through investment trusts. My sipp is about 75% Investment trusts - although diverse largest holdings are Scottish mortgage, arix, monks, herald, oakley, draper, Manchester and london, jp Morgan emerging, schenallion - and just topped up Schroeder public private after loo sing money with woodford. Have few individual shares - two large shareholding s in ENET and OPTI (£50k each) which are very high risk / reward. So a portfolio focused on opportunity not assets which are relevant for banks, utilities, miners etc but not companies lead by IP.
4. I am a qualified management accountant but have not done "accounting" for many years, focus on planning and analysis, financial control and contract management internationally etc. I therefore understand the commercial and financial red flags in their accounts underlying their performance.

Have a great christmas, hope we both have something to celebrate with kromek in q1.

Surprised.
I think we get need to get a trading statement, results, detailed rns for all of us to get some clarity. All I am doing is stating we are pretty much in the dark still, and there are a large range of options which can impact the share price both positively and negatively.
however, it really does show something that we are using nav to value a technology company, incredible.

Wig,
I certainly hope so, and we go up from here.
I think when it hit the lows in the 8p this may have assumed 100% belief of a write off and no recovery of the provision. Maybe where we are assumes a 50 / 50% - but with this going up to say 20p on a recovery of the provision and back down to 8p on a full write off.
The fact that China as a country now seems back up and running, yet no news on this contract getting back to normal is slightly concerning.
More concerning would be is that the issues with this contract show wider financial control issues. Remember the new cf o will be very prudent in accounting treatment, so further issues are covered and he has the potential for release. Also unsure on his share options and when they are priced.

By the way I am a multi year investor here, not a trader

Intellectual property lead technology company, growing worldwide addressable market, high margin and ability to really leverage profit, not reliant on a single revenue streams etc. You can fix management issues, unless you buy a company it is difficult to replicate technical expertise and intellectual property.
I also like to support British companies who provide export opportunities and provide high skilled / well paid jobs, especially outside the South east.
As a shareholder I have the right to ask questions on some pretty basic issues of commercial, contractual and financial control especially as i supported the rights issue - I am amazed these are being discounted by many commentators and they have been brushed under the carpet by the company. The good news is these can be fixed, hopefully the new non exec can buddy up with the CEO and give home some commercial nous, and the new cf o can hopefully being some much needed control.
At the current level price I hope th is represents great value, the market is certainly pricing that the provision is more than likely than not permanent, or pricing in other issues.
Management really need to start delivering after several years of promises and failure to deliver.

Wig.
I am not a seller, but with the information in the market it is really hard to value the company. A positive update will send this higher.
Also I do not think my share volume could move the market !

The main reason for opti and enet is minimal exposure to the UK economy, as well as similar business models ( intellectual property, low fixed costs, zero or minimal variable costs, international exposure, massively leveraged p&l, hopefully no need for further cash raise)

Wool.
It is best to put this into context. This is 10% of my sipp, the main other risk share being ENET, amongst 20 or so diversified investment trusts and a few other individual shares - I also have a £20k final salary pension as a baseline. I am currently breakeven on OPTI. Not a share to stake your mortgage on, not that any share is.
I am an a qualified accountant, therefore prudent and conservative by nature.
This is a 3 - 5 year investment for me, not a trading share.
I hope the q1 results will put a 60- 70p base under the shares for a year or two as an absolute minimum.
Unlike yourself i am not hung up on profit as an absolute. The opportunity to invest from profitAble products into new areas is more important.

I hope results early q1 provide results which impact the share price well for you. If you are in the London area of this is above 70p end jan would love to meet up and buy you a beer or three, virus permitting!

Where is the interview ?
Is it a real interview or just a holly / Phil style interview with boris ? Just strategy blah blah with no detail.

It's not just institutions that are losing faith with the board here.

Key questions
- What is the underlying interest rate in discounting the early payment of £1.5m.
- What did the credit review on the Chinese customer show, and why was it ignored
- Why did the company take a risk on one contract which wiped out a year's revenue and 2/3/4 years profit ?
- Why did you take a contract where you build up a 15m liability
- Why was there no segregation of duty between finance and legal functions
..amongst others

As I have said previously I hope my instincts are incorrect. A lack of an rns is worrying, where are we in reversing the accounting correction ?